Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)
Condition(s):Age Related Macular DegenerationLast Updated:March 16, 2011Completed
Hide Studies Not Open or Pending
Condition(s):Age Related Macular DegenerationLast Updated:March 16, 2011Completed
Condition(s):Age-Related Macular Degeneration; Choroidal NeovascularizationLast Updated:November 29, 2016Completed
Condition(s):Neovascular Age-related Macular DegenerationLast Updated:December 29, 2023Recruiting
Condition(s):Age-related Macular Degeneration (AMD)Last Updated:October 27, 2021Completed
Condition(s):Age-related Macular DegenerationLast Updated:October 17, 2023Completed
Condition(s):Neovascular Age-Related Macular Degeneration (nAMD)Last Updated:May 22, 2023Recruiting
Condition(s):Neovascular Age-related Macular DegenerationLast Updated:December 14, 2023Active, not recruiting
Condition(s):Neovascular Age Related Macular DegenerationLast Updated:September 22, 2020Completed
Condition(s):Age-Related Macular DegenerationLast Updated:January 30, 2023Terminated
Condition(s):Macular DegenerationLast Updated:December 12, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.